NEW YORK, May 18, 2022 /PRNewswire/ — On May 21st– 24th, SoftSmile will make its first public appearance at AAO (American Association of Orthodontists) Annual Session in Miami Beach, Florida. After exhibiting the demo version at the event virtually two years ago, the SoftSmile team is excited to not only attend this important event in person, but also to announce (i) the limited commercial launch and (ii) present their upcoming streaming-powered platform with expanded access capabilities, called SupraVISION.
SupraVISION is a proprietary web viewer and editor that makes access to the treatment planning software more accessible to a broader audience by the following:
SupraVision closes the gap needed to par SoftSmile’s services with industry market leaders. SoftSmile is one of the very few players on the market who can offer a sophisticated web-based editor for doctors that facilitates the overall experience and enhances the interaction among doctors, manufacturers, and patients.
Since SoftSmile first introduced VISION two years ago, the company has achieved significant progress in technology development as well as growth within the business, most importantly with their recent FDA 510(k) Clearance. The company has added breakthrough features to VISION including automated segmentation and staging and introduced unparalleled levels of visualization and aesthetics. SoftSmile team is preparing the CBCT module and other innovations that will be introduced over the next quarter.
“We have built SoftSmile with a mission to make orthodontics affordable and accessible to more people through innovation and science. Our end-to-end treatment planner, VISION, helps to treat complex cases with ease and unprecedented efficiency. In order to accomplish this, we applied geometric concepts developed centuries ago. VISION is proof that an interdisciplinary approach makes it possible to achieve breakthrough results while employing solutions widespread in the other sectors,” says CEO, Khamzat Asabaev. “The same is true for SupraVISION. We learned from gamers how to ensure high-quality access to the most intricate software from any part of the world without compromising functionality or speed. SoftSmile is a company committed to broadening the horizon of orthodontics while combining the daring innovations and widespread solutions from industries beyond medical science. We are proud to present our team and innovations to the AAO guests.”
About SoftSmile, Inc.
SoftSmile is a New York-based innovation technology company that helps orthodontists to deliver custom, high-quality, and affordable treatment to their patients. Established in 2019, SoftSmile designs and develops an advanced, AI-driven orthodontic software package that applies innovative algorithms with sound biomechanical and mathematical principles in a user-friendly interface, giving orthodontists the ability to create aligners treatment plans in-house. These products give orthodontists unparalleled control and precision of the treatment they deliver to their patients. SoftSmile was created by doctors, for doctors.
For additional information about SoftSmile, Inc. please visit https://www.softsmile.com.
Media Contact: Press@SoftSmile.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-tech-company-softsmile-makes-first-public-appearance-at-aao-in-miami-and-introduces-supravision-301550651.html
SOURCE SoftSmile
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…